The Global and Cellular Significance of Environment and Tumor Dynamics on Disease Progression - Gordon Research Conference
- Carmon Emery
- Aug 11
- 1 min read
A number of presentations and publications have been made by the Moses Laboratory led by Dr. Marsha A. Moses at Boston Children’s Hospital and Harvard Medical School. Each of these accomplishments has gratefully acknowledged the essential support of the Nile Albright Research Foundation.
Some of the selected presentations include those at the Gordon Research Conference (Hormone Dependent Cancers) in August 2025, the https://www.aacr.org/meeting/aacr-annual-meeting-2025/program/ in April 2025, the Dana Farber/Harvard Cancer Center Breast and Gynecologic Cancer Symposium in March 2025.
These presentations were focused on the lab’s protein profiling of breast cancer cell-derived extracellular vesicles in breast to bone metastasis and the promotion of breast tumorigenesis by cancer-associated mammary adipocytes from obese women among other related topics.
Recent Publications
Busatto S, Song TH, Kom HJ, Hallinan C, Lombardo MN, Stemmer-Rachmaimov AO,
Lee K, Moses MA. Breast cancer-derived extracellular vesicles modulate the
cytoplasmic and cytoskeletal dynamics of blood-brain barrier endothelial cells. Journal of
Extracellular Vesicles 2025 Jan; 14(1):e70038 PMID: 39868462
Roy R, Schunkert EM, Olivova P, Gilar M, Geromanos S, Li GZ, Gebler J, Dagher A, El-
Hayek A, Aldakhlallah R, Staffa SJ, Zurakowski D, Lotz M, Pories S, Moses MA.
Identification of Vitronectin as a Potential Non-invasive Biomarker of Metastatic Breast
Cancer Using a Label-free LC-MS/MS Approach. Breast Cancer Research; 2025 May
29; 27(1):94 doi.org/10.1186/s13058-025-02053-2. PMID: 40442728
Guo P, Li Y, Huang J, Jin L, Liu X, He D, Moses MA. Therapeutic targeting of
osteosarcoma and lung metastases in preclinical models using a CD24 antibody-drug
conjugate. Advanced Therapeutics 2025; 8(6): 2400423
Comments